Brief: Aurinia to Present New LUPKYNIS® Data at ACR Convergence and ASN Kidney Week 2025
15/10/2025 11:57
Oct 15 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O: AURINIA ANNOUNCES UPCOMING PRESENTATIONS OF NEW DATA ON LUPKYNIS® AT AMERICAN COLLEGE OF RHEUMATOLOGY CONVERGENCE AND AMERICAN SOCIETY OF NEPHROLOGY KIDNEY WEEK 2025 Source text: ID:nBw2HhnSWa Further company coverage: AUPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death